A. Kelleher

A. Kelleher, M. Law, H. Khine, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

AIDS: Clinical Manifestations

D. Cooper, A. Kelleher, A. Pinto, 2014 .

Role of Interleukin-2 in Patients with HIV Infection

A. Kelleher, S. Emery, S. Pett, 2012, Drugs.

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.

D. Cooper, A. Kelleher, J. Zaunders, 1996, The Journal of infectious diseases.

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

D. Hazuda, D. Cooper, H. Teppler, 2007, AIDS.

T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals.

A. Kelleher, J. Zaunders, J. Macpherson, 2012, Clinical immunology.

Dose-Response Relationship of DNA and Recombinant Fowlpox Virus Prime-Boost HIV Vaccines: Implications for Future Trials

D. Cooper, S. Kent, A. Kelleher, 2006, Human vaccines.

Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques

D. Purcell, S. Kent, A. Kelleher, 2020, Scientific Reports.

Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques

S. Alcântara, S. Kent, A. Kelleher, 2019, Scientific Reports.

HIV Vaccines

A. Kelleher, Christopher R. Andersen, C. M. Ling Munier, 2011, Drugs.

Human papillomavirus 16-specific T-cell responses and spontaneous regression of anal high-grade squamous intraepithelial lesions.

S. Garland, A. Kelleher, J. Zaunders, 2015, The Journal of infectious diseases.

Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults

A. Kelleher, A. Grulich, A. Kelleher, 2014, HIV medicine.

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract

Yuan Zhang, A. Kelleher, Chantelle L. Ahlenstiel, 2022, International journal of molecular sciences.

Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape

A. Oxenius, R. Phillips, A. Sewell, 2000, Stem cells.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a pathology distinct from ulcerative colitis

P. Klenerman, R. Scolyer, G. Ahlenstiel, 2020, Clinical and experimental immunology.

Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals.

G. Stewart, D. Cooper, A. Kelleher, 1999, AIDS research and human retroviruses.

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus‐like particle, combined with zidovudine, in asymptomatic subjects

D. Cooper, A. Kelleher, G. Patou, 1998, AIDS.

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1

M. Bebbington, D. Cooper, D. Purcell, 2006, AIDS (London).

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability

H. Jäck, A. Kelleher, K. J. Jackson, 2021, Immunity.

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection

J. Mackay, A. Kelleher, S. Turville, 2021, npj Vaccines.

Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants

P. Phanuphak, A. Kelleher, M. Law, 2021, Journal of acquired immune deficiency syndromes.

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

D. Cooper, A. Kelleher, J. Zaunders, 2000, AIDS.

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.

D. Cooper, A. Kelleher, M. Law, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection

A. Kelleher, J. Zaunders, 2006, Current HIV/AIDS reports.

Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.

D. Cooper, A. Kelleher, J. Zaunders, 2001, AIDS research and human retroviruses.

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

T. Phan, A. Kelleher, J. Zaunders, 2021, Frontiers in Immunology.

Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques

S. Alcântara, S. Kent, A. Kelleher, 2019, Scientific Reports.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

Immunogenicity assay validation for an HIV vaccine trial: high IFNγ+/IL-2+ CD8+ T cells background in healthy Thais.

K. Ruxrungtham, S. Sirivichayakul, A. Kelleher, 2011, Vaccine.

An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection

K. Ruxrungtham, D. Cooper, S. Sirivichayakul, 2010, Human vaccines.

Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency

J. Ananworanich, D. Cooper, A. Kelleher, 2013, PloS one.

Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells

D. Cooper, A. Kelleher, Kazuo Suzuki, 2011, Nucleic acids research.

MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection

A. Kelleher, S. Swaminathan, 2014, Current opinion in HIV and AIDS.

miRNAs and HIV: unforeseen determinants of host‐pathogen interaction

A. Kelleher, D. Murray, S. Swaminathan, 2013, Immunological reviews.

The role of microRNAs in HIV-1 pathogenesis and therapy

A. Kelleher, D. Murray, S. Swaminathan, 2012, AIDS.

Differential Regulation of the Let-7 Family of MicroRNAs in CD4+ T Cells Alters IL-10 Expression

D. Cooper, M. Cowley, A. Kelleher, 2012, The Journal of Immunology.

RNA duplexes in transcriptional regulation

A. Kelleher, Kazuo Suzuki, S. Swaminathan, 2010, Biomolecular concepts.

Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes

S. Tangye, F. Luciani, T. Phan, 2018, Nature Communications.

Achieving HIV-1 Control through RNA-Directed Gene Regulation

F. Caruso, A. Kelleher, F. Cavalieri, 2016, Genes.

Pro‐inflammatory dopamine‐2 receptor‐specific T cells in paediatric movement and psychiatric disorders

A. Kelleher, S. Alexander, R. Dale, 2020, Clinical & translational immunology.

The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.

D. Tscharke, D. Cooper, S. Alcântara, 2016, Vaccine.

Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific

D. Cooper, A. Kelleher, D. Murray, 2011, RNA biology.

Lessons from viral latency in T cells: manipulating HIV‑1 transcription by siRNA

A. Kelleher, Kazuo Suzuki, 2010 .

Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region

D. Cooper, A. Kelleher, Kazuo Suzuki, 2008, Journal of Biological Chemistry.

High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells

T. Phan, A. Kelleher, J. Zaunders, 2022, Frontiers in Immunology.

Clonal dynamics of SARS-CoV-2-specific T cells in children and adults with COVID-19

José Alquicira-Hernández, T. Phan, A. Kelleher, 2022, bioRxiv.

Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription.

D. Cooper, A. Kelleher, Kazuo Suzuki, 2009, Microbes and infection.

Mechanisms for Controlling HIV-1 Infection: A Gene Therapy Approach

A. Kelleher, S. Turville, Chantelle L. Ahlenstiel, 2018, In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders.

The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.

D. Cooper, A. Kelleher, J. Zaunders, 2013, AIDS research and human retroviruses.

Infection of CD127+ (Interleukin-7 Receptor+) CD4+ Cells and Overexpression of CTLA-4 Are Linked to Loss of Antigen-Specific CD4 T Cells during Primary Human Immunodeficiency Virus Type 1 Infection

E. Rosenberg, B. Walker, J. Kaldor, 2006, Journal of Virology.

Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.

S. Kent, A. Kelleher, Adam J Lopez-Denman, 2018, Journal of immunological methods.

The immunosuppressed patient

A. Kelleher, J. Alford, 2009 .

Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro.

D. Cooper, A. Kelleher, Kazuo Suzuki, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes.

P. Easterbrook, A. Oxenius, R. Phillips, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure

S. Kent, A. Kelleher, G. Khoury, 2021, EBioMedicine.

Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages

A. Kelleher, Kazuo Suzuki, P. Hertzog, 2017, Journal of Virology.

Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.

D. Cooper, A. Kelleher, J. Zaunders, 2006, The Journal of infectious diseases.

Human antigen‐specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses

J. Ananworanich, D. Cooper, A. Kelleher, 2014, European journal of immunology.

Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification.

A. Kelleher, J. Amin, A. Carr, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The Role of PKC-θ in CD4+ T Cells and HIV Infection: To the Nucleus and Back Again

A. Kelleher, Chansavath Phetsouphanh, 2015, Front. Immunol..

Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes.

Karen L. Bunting, A. Kelleher, P. Milburn, 2011, Molecular cell.

Functional cure of HIV: the scale of the challenge

S. Lewin, M. Davenport, S. Kent, 2018, Nature Reviews Immunology.

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

W. Selby, A. Kelleher, J. Zaunders, 2006, The Journal of experimental medicine.

The role of T cell immunity in HIV-1 infection.

S. Kent, A. Kelleher, R. De Rose, 2013, Current opinion in virology.

Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

R. Guy, D. V. van Bockel, A. Kelleher, 2020, Viruses.

Impaired Nef Function Is Associated with Early Control of HIV-1 Viremia

E. Rosenberg, H. Jessen, F. Pereyra, 2014, Journal of Virology.

Compensated CD8 Escape Mutations Transmission and Long-Term Stability of

E. Rosenberg, B. Walker, Yaoyu E. Wang, 2012 .

Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers

E. Rosenberg, H. Jessen, F. Pereyra, 2010, Journal of Virology.

HLA FOOTPRINTS ON HIV-1 ARE ASSOCIATED WITH 1

Todd M. Allen, D. Heckerman, B. Walker, 2009 .

Transmission and Long-Term Stability of Compensated CD8 Escape Mutations

Todd M. Allen, E. Rosenberg, H. Jessen, 2008, Journal of Virology.

T-cell responses in primary HIV-1 infection

D. V. van Bockel, A. Kelleher, H. Streeck, 2008, Current opinion in HIV and AIDS.

Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles

E. Rosenberg, M. Altfeld, B. Walker, 2007, Journal of Virology.

Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution

Bin Li, Anthony D. Kelleher, Todd M. Allen, 2006, Journal of Virology.

Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses

Edward C. Holmes, Anthony D. Kelleher, Christian Brander, 2001, The Journal of experimental medicine.

Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure

A. Kelleher, Kazuo Suzuki, Chantelle L. Ahlenstiel, 2015, Front. Immunol..

HIV-1 DNA predicts disease progression and post-treatment virological control

M. Carrington, R. Phillips, D. Cooper, 2014, eLife.

Emergence of Individual HIV-Specific CD8 T Cell Responses during Primary HIV-1 Infection Can Determine Long-Term Disease Outcome

D. Heckerman, E. Rosenberg, H. Jessen, 2014, Journal of Virology.

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing

D. Cooper, A. Kelleher, Kazuo Suzuki, 2013, Molecular therapy. Nucleic acids.

Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells

Anthony D. Kelleher, Hendrik Streeck, Eric S. Rosenberg, 2009, Journal of Virology.

Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells

E. Rosenberg, H. Jessen, M. Altfeld, 2009, Journal of Virology.

Acutely dysregulated, chronically disabled by the enemy within: T‐cell responses to HIV‐1 infection

A. Kelleher, M. Munier, 2007, Immunology and cell biology.

Cytokine therapies in HIV-1 infection: present and future

A. Kelleher, S. Pett, 2003, Expert review of anti-infective therapy.

IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

D. Cooper, A. Kelleher, M. Munier, 2010, Cytokine.

Effects of IL‐2 therapy in asymptomatic HIV‐infected individuals on proliferative responses to mitogens, recall antigens and HIV‐related antigens

A. Kelleher, S. Emery, M. French, 1998, Clinical and experimental immunology.

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

E. Rosenberg, F. Pereyra, T. Miura, 2007, Nature Immunology.

HIV Immune Escape at an Immunodominant Epitope in HLA-B*27–Positive Individuals Predicts Viral Load Outcome

J. Kaldor, D. Cooper, M. Davenport, 2011, The Journal of Immunology.

Trials and tribulations of HIV vaccines

D. Cooper, A. Kelleher, Chris Weatherall, 2009 .

Chapter 6 – Acute HIV infection

D. Cooper, A. Kelleher, 2008 .

Safety, immunogenicity and efficacy of peptide‐pulsed cellular immunotherapy in macaques

L. Loh, J. Reece, C. Fernandez, 2008, Journal of medical primatology.

STI and beyond: the prospects of boosting anti-HIV immune responses.

Todd M. Allen, B. Walker, A. Kelleher, 2002, Trends in immunology.

Differentiating founder and chronic HIV envelope sequences

R. Center, D. Purcell, A. Kelleher, 2017, PloS one.

A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1.

D. Cooper, D. V. van Bockel, A. Kelleher, 2005, AIDS research and human retroviruses.

Frequent Transmission of Cytotoxic-T-Lymphocyte Escape Mutants of Human Immunodeficiency Virus Type 1 in the Highly HLA-A24-Positive Japanese Population

D. Cooper, A. Kelleher, Tetsuya Nakamura, 2004, Journal of Virology.

Pigtail Macaques Tissues during Pathogenic Infection of Follicular Helper CD4 T Cells in Lymphoid Simian Immunodeficiency Virus Infects

J. Corbeil, D. Cooper, A. Kelleher, 2014 .

Short-course antiretroviral therapy in primary HIV infection.

Steve Kaye, Kholoud Porter, Helen Rees, 2013, The New England journal of medicine.

Simian Immunodeficiency Virus Infects Follicular Helper CD4 T Cells in Lymphoid Tissues during Pathogenic Infection of Pigtail Macaques

J. Corbeil, D. Cooper, S. Alcântara, 2013, Journal of Virology.

High Viral Fitness during Acute HIV-1 Infection

A. Kelleher, M. Law, D. McPhee, 2010, PloS one.

Human MAIT cells respond to and suppress HIV-1

Q. Sattentau, P. Klenerman, P. Phalora, 2021, eLife.

First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection.

Anthony D Kelleher, Bin Wang, Nitin K Saksena, 2003, Virology.

Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

D. Cooper, A. Kelleher, J. Zaunders, 1998, The Journal of infectious diseases.

Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells

R. Center, S. Kent, A. Kelleher, 2012, PloS one.

Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes

A. Kelleher, S. Deeks, S. Palmer, 2022, Journal of virology.

T Cell Response + Gag-Specific CD 8 within an Immunodominant HIV Persistent Survival of Prevalent

Cooper, D. Douek, M. Davenport, 2010 .

Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific

S. Rowland-Jones, P. Goulder, G. Ogg, 1998, The Journal of experimental medicine.

Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection

S. Kent, A. Kelleher, J. Zaunders, 2017, Front. Immunol..

Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis

A. Kelleher, M. Law, Q. Pham, 2014, AIDS.

A national study of the molecular epidemiology of HIV-1 in Australia 2005–2012

A. Kelleher, B. Herring, D. Dwyer, 2017, PloS one.

Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Brigitte Autran, Christian Brander, Victor Appay, 2011, Blood.

Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days

S. Lewin, D. Cooper, M. Davenport, 2016, PLoS pathogens.

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

R. Phillips, D. Cooper, C. Willberg, 2015, Nature Communications.

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

Anthony D. Kelleher, David A. Cooper, Miles P. Davenport, 2015, PLoS pathogens.

Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

V. Natarajan, D. Cooper, A. Kelleher, 2015, AIDS.

Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts

D. Cooper, S. Kent, A. Kelleher, 2017, Journal of acquired immune deficiency syndromes.

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells

A. Kelleher, T. Schlub, S. Deeks, 2022, The Journal of clinical investigation.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.

RNAi therapeutics: an antiviral strategy for human infections.

F. Caruso, A. Kelleher, F. Cavalieri, 2020, Current opinion in pharmacology.

Block and Lock HIV Cure Strategies to Control the Latent Reservoir

S. Kent, A. Kelleher, Chantelle L. Ahlenstiel, 2020, Frontiers in Cellular and Infection Microbiology.

Transcriptional Regulation by Promoter Targeted Rnas Post Transcriptional Gene Silencing (ptgs) and Transcriptional Gene Silencing (tgs)

A. Kelleher, Kazuo Suzuki, Anthony D. Kelleher, 2022 .

Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region

John Zaunders, Kazuo Suzuki, David Cooper, 2005, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

D. Cooper, A. McNulty, A. Kelleher, 2018, The lancet. HIV.

Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection.

D. Cooper, A. Kelleher, J. Zaunders, 2002, Virology.

Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals

S. Kent, A. Kelleher, M. Parsons, 2022, Clinical and experimental immunology.

High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2+ T Cell Subset with a MAIT Cell-like Transcriptional Profile.

S. Kent, A. Kelleher, D. Pellicci, 2020, Cell reports.

T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses.

Imogen Moran, Tri Giang Phan, Warren Kaplan, 2015, Immunity.

Immune activation and immune aging in HIV infection

V. Appay, A. Kelleher, 2016, Current opinion in HIV and AIDS.

Early immune adaptation in HIV-1 revealed by population-level approaches

Todd M. Allen, H. Jessen, M. Carrington, 2014, Retrovirology.

Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection

Todd M. Allen, E. Rosenberg, H. Jessen, 2013, Retrovirology.

Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells.

S. Rowland-Jones, A. Kelleher, 2000, Current opinion in immunology.

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort

N. Pantazis, R. Geskus, M. Gill, 2019, AIDS.

Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.

D. Cooper, A. Kelleher, K. Petoumenos, 2018, AIDS research and human retroviruses.

Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.

R. Center, S. Kent, A. Kelleher, 2012, Journal of immunological methods.

Influence of IFNγ Co-Expression on the Safety and Antiviral Efficacy of Recombinant Fowlpox Virus HIV Therapeutic Vaccines Following Interruption of Antiretroviral Therapy

A. Kelleher, S. Emery, R. Puls, 2007, Human vaccines.

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing

D. Cooper, A. Kelleher, Kazuo Suzuki, 2015, Molecular therapy. Nucleic acids.

The microRNA‐9/B‐lymphocyte‐induced maturation protein‐1/IL‐2 axis is differentially regulated in progressive HIV infection

D. Cooper, A. Kelleher, J. Zaunders, 2013, European journal of immunology.

RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency

A. Kelleher, K. Petoumenos, Chantelle L. Ahlenstiel, 2018, Retrovirology.

Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial.

S. Kent, A. Kelleher, M. Law, 2018, The lancet. HIV.

Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+ T cells through p65 and H2B phosphorylation

S. Turner, A. Kelleher, J. Zaunders, 2016, Journal of Cell Science.

The search for an HIV cure: tackling latent infection.

S. Lewin, D. Cooper, J. Reece, 2013, The Lancet. Infectious diseases.

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

S. Lewin, D. Cooper, A. Kelleher, 2017, Journal of acquired immune deficiency syndromes.

HIV dynamics linked to memory CD4+ T cell homeostasis

D. Cooper, A. Kelleher, J. Zaunders, 2017, PloS one.

Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types.

F. Caruso, A. Kelleher, Christina Cortez-Jugo, 2023, Molecular pharmaceutics.

The feasibility of incorporating Vpx into lentiviral gene therapy vectors

A. Kelleher, Kazuo Suzuki, S. Turville, 2016, Molecular therapy. Methods & clinical development.

Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.

J. Corbeil, D. Richman, S. Little, 2003, The Journal of infectious diseases.

TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV.

D. Douek, M. Davenport, P. Scheinberg, 2008, Journal of immunology.

Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical Infectious Diseases.

Altered immune reconstitution in HIV positive allogeneic stem cell transplant recipients.

S. Lewin, A. Kelleher, J. Zaunders, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute treatment with monoclonal antibodies: their design and their use

A. Kelleher, 2021 .

Immunological effects of antiretroviral and immune therapies for HIV.

A. Kelleher, A. Landay, L. Al-Harthi, 1997, AIDS.

P90: LANADELUMAB EFFICACY AND SAFETY REGARDLESS OF BASELINE ATTACK RATE IN PATIENTS WITH PREVIOUS LONG‐TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA: A POST HOC SUBANALYSIS OF HELP OLE

Louise, A. Kelleher, E. Deenick, 2022 .

Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence

A. Chughtai, C. Macintyre, A. Kelleher, 2018, Emerging infectious diseases.

Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand

A. McNulty, A. Kelleher, James Douglas Allan Gray, 2021, AIDS and Behavior.

HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia

A. Kelleher, D. Dwyer, A. Castley, 2018, Future Virology.

Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment.

A. Kelleher, M. Law, M. Pitts, 2008, Sexual health.

No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001.

D. Cooper, A. Kelleher, Kazuo Suzuki, 2003, AIDS.

Three-Year Immune Reconstitution in PI-Sparing and PI-Containing Antiretroviral Regimens in Advanced HIV-1 Disease

A. Samri, B. Autran, G. Pantaleo, 2007, Antiviral therapy.

Rates of transmission of antiretroviral drug resistant strains of HIV-1.

D. Cooper, A. Kelleher, Kazuo Suzuki, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT

K. Ruxrungtham, A. Kelleher, M. Karyana, 2022, HIV research & clinical practice.

Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults

D. Cooper, A. Kelleher, S. Emery, 2010 .

1.2 Strategies of care in managing HIV

A. Kelleher, A. Wodak, S. Irvine, 1996, The Medical journal of Australia.

High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)1

D. Cooper, S. Kent, A. Kelleher, 2009, The Journal of Immunology.

HIV‐specific antibody‐dependent phagocytosis matures during HIV infection

Jerome H. Kim, R. Center, S. Kent, 2014, Immunology and cell biology.

Role of monocytes in mediating HIV-specific antibody-dependent cellular 5 cytotoxicity 6 7

S. Kent, A. Kelleher, A. Johnston, 2014 .

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

S. Tangye, D. Stark, A. Kelleher, 2023, eBioMedicine.

Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort study.

Anne M Johnson, C. Morrison, N. Pantazis, 2014, The lancet. HIV.

Antiretroviral therapy-induced immune restoration in HIV infection: a double-edged sword?

A. Kelleher, S. Pett, 2004, Expert review of anti-infective therapy.

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

E. Rosenberg, B. Walker, J. Kaldor, 2005, Blood.

Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.

D. Douek, D. Cooper, M. Davenport, 2007, Journal of immunological methods.

Transmission of triple‐class, drug‐resistant HIV‐1 in Australia

A. Kelleher, P. White, A. Carr, 2010, Internal medicine journal.

Specific antibody‐dependent cellular cytotoxicity responses associated with slow progression of HIV infection

D. Cooper, S. Kent, A. Kelleher, 2013, Immunology.

Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.

D. Cooper, A. Kelleher, S. Emery, 2008, The Journal of infectious diseases.

A Randomised Trial Comparing Genotypic and Virtual Phenotypic Interpretation of HIV Drug Resistance: The CREST Study

A. Kelleher, M. Law, S. Emery, 2006, PLoS clinical trials.

Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

V. Natarajan, D. Cooper, A. Kelleher, 2011, AIDS.

Circulating gluten‐specific, but not CMV‐specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire

A. Kelleher, J. Zaunders, L. Cook, 2020, Clinical & translational immunology.

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

D. Cooper, A. Kelleher, J. Zaunders, 2012, AIDS.

HIV DNA Subspecies Persist in both Activated and Resting Memory CD4+ T Cells during Antiretroviral Therapy

D. Cooper, A. Kelleher, J. Zaunders, 2014, Journal of Virology.

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment

N. Pantazis, A. Kelleher, D. Costagliola, 2016, AIDS.

Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

D. Cooper, A. Kelleher, J. Amin, 2012, PloS one.

miR-155 is differentially expressed in Treg subsets, which may explain expression level differences of miR-155 in HIV-1 infected patients.

A. Kelleher, C. Phetsouphanh, S. Swaminathan, 2012, Blood.

Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?

A. Kelleher, J. Zaunders, Kazuo Suzuki, 2009, Blood.

Parallel analysis of multiple human memory CD4+ T‐cell subsets within antigen‐specific responses using cell proliferation dyes

A. Kelleher, J. Zaunders, L. Cook, 2022, Immunology and cell biology.

Comment on “A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood”

A. Kelleher, J. Zaunders, L. Cook, 2016, The Journal of Immunology.

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion.

M. Rosińska, A. Kelleher, L. Meyer, 2012, Archives of internal medicine.

Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty

Anthony D Kelleher, S. Lewin, M. Davenport, 2003, Immunology and cell biology.

Ratios of effector to central memory antigen‐specific CD4+ T cells vary with antigen exposure in HIV+ patients

A. Kelleher, J. Zaunders, S. Pett, 2014, Immunology and cell biology.

T follicular helper cell responses to SARS‐CoV‐2 vaccination among healthy and immunocompromised adults

A. Kelleher, C. Munier, Mollie Ailie Acheson Boyd, 2023, Immunology and cell biology.

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.

D. Cooper, A. Leigh Brown, A. Kelleher, 2019, AIDS research and human retroviruses.

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.

D. Cooper, A. Kelleher, J. Zaunders, 1999, The Journal of infectious diseases.

Stimulated Coexpression of CD 25 and T Cells in Peripheral Blood Revealed by + High Levels of Human Antigen-Specific CD 4

D. Cooper, S. Kent, A. Kelleher, 2009 .

Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals

M. Johnson, A. Kelleher, D. Murray, 2017, Scientific Reports.

The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC

B. Brew, A. Kelleher, G. Dore, 2023, Annals of clinical and translational neurology.

A case of severe visceral leishmaniasis resulting from travel to Greece

A. Kelleher, D. Marriott, Alexander Hamilton, 2009, BMJ Case Reports.

Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models

S. Lewin, S. Kent, A. Kelleher, 2019, Journal of Virology.

Modulation of the CCR 5 receptor / ligand axis by seminal plasma and the utility of in vitro 1 versus in vivo models 2 Running head : Chemokine regulation by semen 3 4

S. Lewin, S. Kent, A. Kelleher, 2019 .

Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms

Holden Maecker, Junmei Jing, John Zaunders, 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Restoration of anti‐tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

A. Samri, B. Autran, G. Pantaleo, 2008, Clinical and experimental immunology.

Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy.

D. Cooper, A. Kelleher, J. Zaunders, 2017, AIDS research and human retroviruses.

Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling.

S. Lewin, D. Cooper, A. Kelleher, 2001, AIDS research and human retroviruses.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection: Final Results From a Randomized Clinical Trial (Pulse)

J. Kaldor, D. Cooper, A. Kelleher, 2006, Journal of acquired immune deficiency syndromes.

Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects

A. Kelleher, S. Emery, R. Puls, 2005, Human vaccines.

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy

A. Kelleher, S. Turville, F. Brilot, 2023, eJHaem.

Dyslipidemia due to retroviral protease inhibitors

A. Sewell, A. Kelleher, D. Price, 2002, Nature Medicine.

Improvement of immune dysregulation and health-related quality of life in individuals with long COVID at 24-months following SARS-CoV-2 infection

B. Brew, A. Kelleher, G. Dore, 2023, medRxiv.

Explaining the Determinants of First Phase HIV Decay Dynamics through the Effects of Stage-dependent Drug Action

David A. Cooper, James B. Gilmore, Anthony D. Kelleher, 2013, PLoS Comput. Biol..

Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency

S. Tangye, M. Cowley, T. Phan, 2018, Journal of Clinical Immunology.

Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals

M. Johnson, A. Kelleher, Kazuo Suzuki, 2017, Scientific Reports.

Single-cell profiling of lineage determining transcription factors in antigen-specific CD4+ T cells reveals unexpected complexity in recall responses during immune reconstitution

A. Kelleher, M. Munier, J. Zaunders, 2017, Immunology and cell biology.

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.

Yuan Zhang, A. Kelleher, F. Di Giallonardo, 2023, Antiviral research.

Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response

T. Phan, A. Kelleher, J. Zaunders, 2021, iScience.

Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.

J. Ananworanich, D. Cooper, R. Center, 2015, The Journal of infectious diseases.

The search for an HIV cure: tackling latent infection.

S. Lewin, D. Cooper, J. Reece, 2013, The Lancet. Infectious diseases.

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

G. Carcelain, C. Katlama, B. Autran, 2011, Blood.

Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis

A. Kelleher, M. Law, Q. Pham, 2014, AIDS.

Human antigen‐specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses

J. Ananworanich, D. Cooper, A. Kelleher, 2014, European journal of immunology.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study

A. Kelleher, C. Katelaris, D. Campbell, 2022, Journal of Allergy and Clinical Immunology: Global.

Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency

S. Tangye, M. Cowley, T. Phan, 2018, Journal of Clinical Immunology.

Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

D. Cooper, A. McNulty, A. Kelleher, 2018, The lancet. HIV.

Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity

D. Heckerman, E. Rosenberg, H. Jessen, 2012, Journal of Virology.

Early Selection in Gag by Protective HLA Alleles Contributes to Reduced HIV-1 Replication Capacity That May Be Largely Compensated for in Chronic Infection

Todd M. Allen, D. Heckerman, E. Rosenberg, 2010, Journal of Virology.

Functional cure of HIV: the scale of the challenge

S. Lewin, M. Davenport, S. Kent, 2018, Nature Reviews Immunology.

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV

A. Kelleher, S. Emery, J. Amin, 2017, Journal of Virology.

P. Klenerman, R. Scolyer, G. Ahlenstiel, 2020, Clinical and experimental immunology.

MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection

A. Kelleher, S. Swaminathan, 2014, Current opinion in HIV and AIDS.

miRNAs and HIV: unforeseen determinants of host‐pathogen interaction

A. Kelleher, S. Swaminathan, Daniel D. Murray, 2013, Immunological reviews.

HLA Alleles Association with Changes in Bone Mineral Density in HIV-1-Infected Adults Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

A. Kelleher, S. Emery, J. Amin, 2014, PloS one.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.

Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults

A. Kelleher, A. Grulich, A. Carr, 2014, HIV medicine.

Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.

A. Kelleher, S. Emery, K. Petoumenos, 2009, AIDS research and human retroviruses.

Obituary: David Cooper, transformative clinician scientist

J. Kaldor, A. Kelleher, D. Draganic, 2018 .

AIDS: Clinical Manifestations

D. Cooper, A. Kelleher, A. Pinto, 2014 .

Transcriptional regulation by promoter targeted RNAs.

A. Kelleher, Kazuo Suzuki, 2009, Current topics in medicinal chemistry.